29 results
8-K
EX-10.8
YBGJ
Yubo International Biotech Ltd
14 Jan 21
Entry into a Material Definitive Agreement
2:54pm
A is a high-tech R&D center in the biomedicine field, which owns numerous core patent technologies and GMP standard laboratory environment. Its expert
SC 14F1
YBGJ
Yubo International Biotech Ltd
6 Jul 20
Statement regarding change in majority of directors
11:39am
experience and Mr. Joel S. Kanter is deemed an "audit committee financial expert" within the meaning of Securities and Exchange Commission regulations … is deemed an "audit committee financial expert" within the meaning of Securities and Exchange Commission regulations as defined in Item 401 of Regulation S-B
S-1
EX-10.8
YBGJ
Yubo International Biotech Ltd
6 May 21
IPO registration
6:03am
A is a high-tech R&D center in the biomedicine field, which owns numerous core patent technologies and GMP standard laboratory environment. Its expert
8-K
EX-10.1
YBGJ
Yubo International Biotech Ltd
3 Nov 05
Entry into a Material Definitive Agreement
12:00am
for the
arbitrator's fee, reasonable legal fees, expert testimony, costs, and expenses
incurred in connection with any contest or dispute with respect
10-K
x94ey14va3aqz0q
12 Jun 09
Annual report
12:00am
S-1
mfnxa zzwnm
6 May 21
IPO registration
6:03am
10-KT
z53r 4b5v
23 Apr 21
Annual report (with FYE transition)
5:05pm
S-1/A
ulo5e s4hmqp2r875sg4
12 Jul 21
IPO registration (amended)
4:50pm